BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Apr 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-04-02

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-02	Common Stock	M	3350	$26.49	Acquired	160026	Direct
2018-04-02	Common Stock	S	3350	$80.12	Disposed	156676	Direct
2018-04-02	Common Stock	M	6650	$37.46	Acquired	163326	Direct
2018-04-02	Common Stock	S	6650	$80.12	Disposed	156676	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-02	Stock Option (Right to buy Common Stock)	$26.49	M	3350	Disposed	2021-05-11	Common Stock (3350)	Direct
2018-04-02	Stock Option (Right to buy Common Stock)	$37.46	M	6650	Disposed	2022-05-07	Common Stock (6650)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.